U chemists discover enzyme that could help build next-generation GLP-1 drugs
PapB ‘ties off’ peptides, paving way for stronger, longer-lasting versions of medications used to treat obesity and diabetes.
Read MorePapB ‘ties off’ peptides, paving way for stronger, longer-lasting versions of medications used to treat obesity and diabetes.
Read MoreThe authors hypothesize that rapid changes in blood sugar induced by these drugs may contribute to the complications.
Read More